21.1 - Manufacture of basic pharmaceutical substances
21.2 - Manufacture of medicines and other pharmaceutical products
47.19 - Other retail sale in non-specialised stores
47.73 - Dispensing chemist in specialised stores
47.74 - Retail sale of medical and orthopaedic goods in specialised stores
47.75 - Retail sale of cosmetic and toilet articles in specialised stores
47.78 - Other retail sale of new goods in specialised stores
47.91 - Retail sale via mail order houses or via Internet
52.10.B - Warehousing and storage of other goods
72.19.Z - Other research and experimental development on natural sciences and engineering
96.09 - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -1,9 | -0,3 | 0 | 100 |
EBITDA | -1 | -0,3 | 0 | 100 |
Short time liabilities | 258,7 | 258,9 | 258,9 | 0 |
Equity capital | -249,3 | -251,2 | -251,5 | -0,1 |
Operating profit (EBIT) | -1 | -0,3 | 0 | 100 |
Assets | 7,6 | 7,4 | 7,4 | 0 |
Net profit (loss) | -1,9 | -0,3 | 0 | 100 |
Cash | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 258,7 | 258,9 | 258,9 | 0 |
Net income from sale | 32,4 | 0 | 0 | 0 |
Working assets | 7,6 | 7,4 | 7,4 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0,7 | 0,1 | 0 | -0,1 |
Equity capital to total assets | -3301,9 | -3401,8 | -3406,1 | -4,3 |
Gross profit margin | -5,7 | -44,9 | ||
EBITDA Margin | -3,2 | -34,3 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2916 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.02918507158756256 | 0.028522025793790817 | 0.028522025793790817 | 0 |
Net dept to EBITDA | -0.10029056668281555 | -0.3252750039100647 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane